[HTML][HTML] Mechanisms of CYP450 inhibition: understanding drug-drug interactions due to mechanism-based inhibition in clinical practice

…, SB Al Rihani, MJ Arwood, L Darakjian, P Dow… - Pharmaceutics, 2020 - mdpi.com
In an ageing society, polypharmacy has become a major public health and economic issue.
Overuse of medications, especially in patients with chronic diseases, carries major health …

[HTML][HTML] Quantifying anticholinergic burden and sedative load in older adults with polypharmacy: a systematic review of risk scales and models

SB Al Rihani, M Deodhar, LI Darakjian, P Dow… - Drugs & Aging, 2021 - Springer
Background Patients taking medication with high anticholinergic and sedative properties are
at increased risk of experiencing poor cognitive and physical outcomes. Therefore, precise …

Risk assessment of drug‐induced long QT syndrome for some COVID‐19 repurposed drugs

V Michaud, P Dow, SB Al Rihani… - Clinical and …, 2021 - Wiley Online Library
The risk‐benefit ratio associated with the use of repurposed drugs to treat severe acute
respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2)‐related infectious coronavirus disease 2019 …

[HTML][HTML] ACE2 as a therapeutic target for COVID-19; its role in infectious processes and regulation by modulators of the RAAS system

…, M Deodhar, M Arwood, SB Al Rihani, P Dow… - Journal of Clinical …, 2020 - mdpi.com
Angiotensin converting enzyme 2 (ACE2) is the recognized host cell receptor responsible
for mediating infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …

[HTML][HTML] Disease-induced modulation of drug transporters at the blood–brain barrier level

SB Al Rihani, LI Darakjian, M Deodhar, P Dow… - International Journal of …, 2021 - mdpi.com
The blood–brain barrier (BBB) is a highly selective and restrictive semipermeable network
of cells and blood vessel constituents. All components of the neurovascular unit give to the …

[HTML][HTML] Risk of adverse drug events following the virtual addition of COVID-19 repurposed drugs to drug regimens of frail older adults with polypharmacy

…, MK Smith, R Bikmetov, M Deodhar, P Dow… - Journal of clinical …, 2020 - mdpi.com
Determination of the risk–benefit ratio associated with the use of novel coronavirus disease
2019 (COVID-19) repurposed drugs in older adults with polypharmacy is mandatory. Our …

Association of the MedWise Risk Score with health care outcomes.

…, MK Smith, R Bikmetov, P Dow… - American Journal of …, 2021 - search.ebscohost.com
Objectives: Older patients are especially vulnerable to drug-related problems due to multiple
prescription drugs, which increases their risk of drug-drug interactions and adverse drug …

Physiologically based pharmacokinetic modeling to assess the impact of CYP2D6‐mediated drug‐drug interactions on tramadol and O‐desmethyltramadol exposures …

…, B Cicali, V Michaud, P Dow… - The Journal of …, 2022 - Wiley Online Library
Tramadol is an opioid medication used to treat moderately severe pain. Cytochrome P450 (CYP)
2D6 inhibition could be important for tramadol, as it decreases the formation of its …

Risk of drug-induced Long QT Syndrome associated with the use of repurposed COVID-19 drugs: A systematic review

V Michaud, P Dow, SBA Rihani, M Deodhar, M Arwood… - MedRxiv, 2020 - medrxiv.org
Objective To determine the relative risk of drug-induced Long QT Syndrome (LQTS)
associated with SARS-CoV-2 (COVID-19) proposed repurposed drugs compared to well-known …

Multidrug Interactions: Why Do They Occur and How to Handle?

P Dow, V Michaud, J Turgeon - Clinical Therapeutics, 2023 - Elsevier
A nonoptimized medication therapy (NOMT) event is an iatrogenic hazard or incident
associated with medications and is a leading cause of death, serious injury, and illness. NOMT …